- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Merck Ratings Report.
Stocks are lower Monday as Wall Street's attention shifts to the looming presidential debate from central bank policy.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.